Use of Topical Budesonide in the Treatment of Eosinophilic Esophagitis, a Randomized Clinical Trial

NCT00638456 Phase 2 COMPLETED Results posted

This study is designed to evaluate whether or not oral viscous budesonide is effective in treating children with Eosinophilic Esophagitis.

Details

Lead sponsor	Ranjan Dohil
Phase	Phase 2
Status	COMPLETED
Enrolment	32
Start date	2008-02
Completion	2009-09

Conditions

• Eosinophilic Esophagitis

Interventions

• Budesonide plus Prevacid
• placebo plus Prevacid

Primary outcomes

• Number of Participants With Improvement of Espohageal Eosinophilia — 3 Months
  Repeat endoscopy was undertaken using the Olympus P160 endoscope (by RD) at 3 months of treatment.

Countries

United States